The Global Surgical Sealants And Adhesives Market size is expected to reach $5.7 billion by 2031, rising at a market growth of 11.3% CAGR during the forecast period.
The exceptional biocompatibility of polymeric hydrogels reduces the likelihood of detrimental or inflammatory reactions upon contact with biological tissues. This biocompatibility ensures patient safety and promotes optimal wound healing outcomes. Consequently, the polymeric hydrogels segment would acquire approximately 30.17 % share of the market by 2031. Hydrogels interact with tissues gently and non-disruptively, forming conformal seals or adhesions without causing tissue trauma or irritation. Therefore, these factors can assist in the growth of the segment.
Continuous advancements in medical technology have broadened the scope of surgical interventions, making procedures more accessible, efficient, and effective. Innovations such as robotic-assisted surgery, minimally invasive techniques, and enhanced imaging technologies have expanded the range of conditions treatable through surgery. Hence, these aspects will drive the growth of the market.
Additionally, MIS techniques offer numerous advantages over traditional open surgeries, making them increasingly popular among patients and healthcare providers. These advantages include reduced blood loss, smaller incisions, a shortened risk of infection, expedited recovery, shorter hospital stays, and diminished postoperative pain. Thus, these aspects can pose lucrative growth prospects for the market.
However, Bringing a new surgical sealant or adhesive to market involves rigorous testing to demonstrate its safety and effectiveness in various clinical settings. This testing typically includes preclinical studies to assess biocompatibility, toxicity, and mechanical properties, followed by clinical trials involving human subjects. Thus, owing to these factors, there can be a decreased demand for surgical sealants and adhesives.
Furthermore, in response to the heightened emphasis on infection prevention and control during the pandemic, there was a growing demand for sealant and adhesive products with antimicrobial properties. Surgeons and healthcare facilities prioritized products that provided effective wound closure and hemostasis and offered additional protection against healthcare-associated infections. Hence, the COVID-19 pandemic had a moderate impact on the market.
Drivers 
Restraints 
Opportunities 
Challenges Based on type, the market is segmented into natural or biological and synthetic & semi synthetic. The natural or biological segment held the 64.29 % revenue share in the market in 2023. As sustainability becomes a priority across industries, including healthcare, there is a growing demand for greener, more sustainable alternatives that minimize environmental footprint throughout their lifecycle. Thus, these factors will assist in the growth of the segment.
The natural or biological segment is segmented into fibrin sealants, collagen-based adhesives, and gelatin-based adhesives. The fibrin sealants segment recorded a 49.07 % revenue share in the market in 2023. The growing utilization of robotic-assisted, laparoscopic, endoscopic, and other minimally invasive surgical techniques has stimulated the need for sophisticated hemostatic and sealing agents, including fibrin sealants. These sealants offer precise application, effective tissue adherence, and rapid hemostasis, making them well-suited for minimally invasive approaches where access to bleeding sites may be limited. Hence, the segment will grow rapidly in the coming years.
The synthetic and semi synthetic segment is further divided into cyanoacrylates, polymeric hydrogels, and urethane-based adhesives. In 2023, the cyanoacrylates segment witnessed a 54.36 % revenue share in the market. Cyanoacrylate adhesives are renowned for achieving rapid hemostasis and tissue sealing, making them invaluable tools in surgical procedures where efficient bleeding control and wound closure are paramount. Therefore, owing to these aspects, the segment will expand rapidly.
On the basis of indication, the market is divided into tissue sealing, tissue engineering, and hemostasis. In 2023, the tissue engineering segment witnessed a 24.36 % revenue share in the market. Tissue engineering represents a cutting-edge approach to addressing tissue defects, injuries, and organ dysfunction by harnessing biology, engineering, and materials science principles to regenerate or replace damaged tissues and organs. Therefore, owing to these factors, the segment will witness increased demand in the upcoming years.
Based on application, the market is divided into central nervous system, cardiovascular, general surgery, orthopedic, cosmetic, pulmonary, urology, ophthalmology, and others. The general surgery segment recorded a 23.86% revenue share in the market in 2023. The increasing prevalence of chronic diseases, the aging population, and the expanding healthcare infrastructure have led to a rise in the volume of general surgical procedures globally. Thus, these factors can lead to increased demand in the segment.
Free Valuable Insights: Global Surgical Sealants and Adhesives Market size to reach USD 5.7 Billion by 2031
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2023, the Europe segment acquired a 29.53% revenue share in the market. European healthcare systems prioritize patient safety, quality of care, and evidence-based practices. Surgical sealants and adhesives offer advantages in reducing the risk of postoperative complications, such as bleeding, infections, and wound dehiscence, aligning with the region's focus on improving surgical outcomes. Therefore, these aspects can help in the growth of the segment.
| Report Attribute | Details |
|---|---|
| Market size value in 2023 | USD 2.4 Billion |
| Market size forecast in 2031 | USD 5.7 Billion |
| Base Year | 2023 |
| Historical Period | 2020 to 2022 |
| Forecast Period | 2024 to 2031 |
| Revenue Growth Rate | CAGR of 11.3% from 2024 to 2031 |
| Number of Pages | 353 |
| Number of Tables | 580 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Type, Indication, Application, Region |
| Country scope |
|
| Companies Included | Johnson & Johnson (Ethicon, Inc.), Artivion, Inc (CryoLife, Inc.), Becton, Dickinson, and Company, Medtronic PLC, B. Braun Melsungen AG, Medline Industries, LP, Cardinal Health, Inc., Baxter International, Inc.Integra LifeSciences Holdings Corporation, Stryker Corporation |
By Type
By Indication
By Application
By Geography
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
